The Pristina Via mammography system, which has been introduced by GE HealthCare, is intended to enhance the screening experience for both technologists and patients. Pristina Via provides technologists with the ability to concentrate on the provision of personalized care by offering advanced features that simplify workflows and minimize repetitive tasks. The demand for intelligent and efficient workflows is critical in the face of a global shortage of mammography technologists. Pristina Via incorporates the lowest radiation dose among key mammography systems, vendor-neutral prior image comparison, zero-click acquisition functionality, and no wait time between exposures, thereby guaranteeing quicker and more accurate diagnostics.
As part of the patient-centric Senographe Pristina platform, Pristina Via continues GE HealthCare's commitment to innovation. Jyoti Gupta, President and CEO for Women’s Health and X-rays at GE HealthCare, highlighted that Pristina Via minimizes laborious tasks, enabling technologists to prioritize patient-centered care. The system's advanced features were developed following nearly 250 interviews and observations with mammography technologists, addressing the challenge of maintaining accuracy in a fast-paced environment. GE HealthCare, a global leader in medical technology and diagnostics, remains dedicated to advancing personalized, connected, and compassionate care, contributing to better patient outcomes and more efficient healthcare systems.
